2023 Q2 Form 10-Q Financial Statement
#000143774923014633 Filed on May 15, 2023
Income Statement
Concept | 2023 Q2 | 2023 Q1 | 2022 Q4 |
---|---|---|---|
Revenue | $14.76M | $10.74M | $5.370M |
YoY Change | 84.52% | 44.04% | -22.16% |
Cost Of Revenue | $8.795M | $6.330M | $3.182M |
YoY Change | 102.93% | 51.33% | -20.21% |
Gross Profit | $5.965M | $4.408M | $2.188M |
YoY Change | 62.76% | 34.72% | -24.84% |
Gross Profit Margin | 40.41% | 41.05% | 40.74% |
Selling, General & Admin | $3.243M | $2.344M | $1.390M |
YoY Change | 77.89% | 41.03% | -10.9% |
% of Gross Profit | 54.37% | 53.18% | 63.53% |
Research & Development | |||
YoY Change | |||
% of Gross Profit | |||
Depreciation & Amortization | $13.00K | $19.00K | $17.00K |
YoY Change | 85.71% | 35.71% | -5.56% |
% of Gross Profit | 0.22% | 0.43% | 0.78% |
Operating Expenses | $3.381M | $3.735M | $1.407M |
YoY Change | 83.75% | 122.85% | -10.84% |
Operating Profit | $2.584M | $673.0K | $781.0K |
YoY Change | 41.59% | -57.83% | -41.41% |
Interest Expense | $251.0K | $98.00K | $62.00K |
YoY Change | 2688.89% | 1300.0% | 785.71% |
% of Operating Profit | 9.71% | 14.56% | 7.94% |
Other Income/Expense, Net | $15.00K | -$96.00K | |
YoY Change | 66.67% | -1471.43% | |
Pretax Income | $2.599M | $577.0K | $800.0K |
YoY Change | 41.71% | -64.0% | -40.3% |
Income Tax | $635.0K | $421.0K | $327.0K |
% Of Pretax Income | 24.43% | 72.96% | 40.88% |
Net Earnings | $1.964M | $156.0K | $473.0K |
YoY Change | 35.82% | -87.91% | -55.04% |
Net Earnings / Revenue | 13.31% | 1.45% | 8.81% |
Basic Earnings Per Share | $0.44 | $0.03 | |
Diluted Earnings Per Share | $0.40 | $0.03 | $0.10 |
COMMON SHARES | |||
Basic Shares Outstanding | 4.446M | 4.446M | 4.556M |
Diluted Shares Outstanding | 4.887M | 4.935M |
Balance Sheet
Concept | 2023 Q2 | 2023 Q1 | 2022 Q4 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $8.882M | $7.977M | $13.28M |
YoY Change | -27.81% | -27.88% | 34.15% |
Cash & Equivalents | $9.833M | $8.927M | $13.28M |
Short-Term Investments | |||
Other Short-Term Assets | $1.520M | $2.397M | $116.0K |
YoY Change | 198.04% | 1352.73% | -60.68% |
Inventory | $9.148M | $8.791M | $9.105M |
Prepaid Expenses | |||
Receivables | $1.575M | $2.045M | $705.0K |
Other Receivables | $1.322M | $0.00 | $0.00 |
Total Short-Term Assets | $22.45M | $21.21M | $23.20M |
YoY Change | 5.46% | 6.0% | 31.41% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $162.0K | $118.0K | $46.00K |
YoY Change | 174.58% | 100.0% | -79.82% |
Goodwill | $13.56M | $10.79M | $358.0K |
YoY Change | 3687.43% | 2913.13% | 0.0% |
Intangibles | $7.957M | $7.769M | $150.0K |
YoY Change | 4553.22% | 4192.27% | -21.88% |
Long-Term Investments | |||
YoY Change | |||
Other Assets | $1.344M | $1.596M | $1.847M |
YoY Change | -42.86% | -41.67% | -39.34% |
Total Long-Term Assets | $23.19M | $20.46M | $2.504M |
YoY Change | 655.03% | 486.94% | -34.5% |
TOTAL ASSETS | |||
Total Short-Term Assets | $22.45M | $21.21M | $23.20M |
Total Long-Term Assets | $23.19M | $20.46M | $2.504M |
Total Assets | $45.63M | $41.67M | $25.71M |
YoY Change | 87.37% | 77.34% | 19.68% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $3.571M | $4.881M | $2.995M |
YoY Change | 41.99% | 43.1% | 3.99% |
Accrued Expenses | $3.157M | $1.987M | $685.0K |
YoY Change | 288.31% | 250.44% | 18.31% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | $2.500M | $2.500M | $0.00 |
YoY Change | |||
Total Short-Term Liabilities | $9.817M | $9.949M | $4.270M |
YoY Change | 147.65% | 114.79% | 4.38% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $9.375M | $10.00M | $0.00 |
YoY Change | |||
Other Long-Term Liabilities | $85.00K | $108.0K | $49.00K |
YoY Change | 11.84% | 20.0% | -52.43% |
Total Long-Term Liabilities | $9.375M | $10.00M | $49.00K |
YoY Change | 12235.53% | 11011.11% | -52.43% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $9.817M | $9.949M | $4.270M |
Total Long-Term Liabilities | $9.375M | $10.00M | $49.00K |
Total Liabilities | $21.78M | $20.06M | $4.319M |
YoY Change | 439.21% | 324.76% | 2.98% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$6.593M | -$8.557M | -$8.713M |
YoY Change | -36.64% | -27.8% | -33.7% |
Common Stock | $44.00K | $44.00K | $45.00K |
YoY Change | -4.35% | -4.35% | -2.17% |
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | $0.00 | ||
YoY Change | -100.0% | ||
Treasury Stock Shares | $0.00 | ||
Shareholders Equity | $23.85M | $21.61M | $21.39M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $45.63M | $41.67M | $25.71M |
YoY Change | 87.37% | 77.34% | 19.68% |
Cashflow Statement
Concept | 2023 Q2 | 2023 Q1 | 2022 Q4 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | $1.964M | $156.0K | $473.0K |
YoY Change | 35.82% | -87.91% | -55.04% |
Depreciation, Depletion And Amortization | $13.00K | $19.00K | $17.00K |
YoY Change | 85.71% | 35.71% | -5.56% |
Cash From Operating Activities | $1.562M | $232.0K | -$873.0K |
YoY Change | 25.56% | -79.54% | -168.2% |
INVESTING ACTIVITIES | |||
Capital Expenditures | $54.00K | $0.00 | |
YoY Change | |||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | $0.00 | -$17.10M | $0.00 |
YoY Change | |||
Cash From Investing Activities | -$54.00K | -$17.10M | $0.00 |
YoY Change | |||
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | $0.00 | ||
YoY Change | |||
Cash From Financing Activities | -625.0K | $12.50M | -779.0K |
YoY Change | 43003.45% | ||
NET CHANGE | |||
Cash From Operating Activities | 1.562M | $232.0K | -873.0K |
Cash From Investing Activities | -54.00K | -$17.10M | 0.000 |
Cash From Financing Activities | -625.0K | $12.50M | -779.0K |
Net Change In Cash | 883.0K | -$4.350M | -1.652M |
YoY Change | -29.02% | -474.03% | -229.06% |
FREE CASH FLOW | |||
Cash From Operating Activities | $1.562M | $232.0K | -$873.0K |
Capital Expenditures | $54.00K | $0.00 | |
Free Cash Flow | $1.508M | $232.0K | |
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2023Q1 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2023Q1 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2023Q1 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q1 | |
CY2023Q1 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2023 | |
CY2023Q1 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
36000 | usd |
CY2022Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
50000 | usd |
CY2023Q1 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
110000 | usd |
CY2022Q4 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
107000 | usd |
CY2023Q1 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
82000 | usd |
CY2022Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
72000 | usd |
CY2023Q1 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.01 | |
CY2022Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.01 | |
CY2023Q1 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000 | |
CY2022Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000 | |
CY2023Q1 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
CY2022Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
CY2023Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
CY2022Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
CY2023Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
60000000 | |
CY2022Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
60000000 | |
CY2023Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
4446000 | |
CY2023Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
4446000 | |
CY2022Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
4507000 | |
CY2022Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
4507000 | |
CY2022Q4 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
143000 | |
CY2023Q1 | dei |
Document Type
DocumentType
|
10-Q | |
CY2023Q1 | dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | |
CY2023Q1 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2023-03-31 | |
CY2023Q1 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
CY2023Q1 | dei |
Entity File Number
EntityFileNumber
|
000-52369 | |
CY2023Q1 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
NV | |
CY2023Q1 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
20-3464383 | |
CY2023Q1 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
5214 S. 136th Street | |
CY2023Q1 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Omaha | |
CY2023Q1 | dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
NE | |
CY2023Q1 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
68137 | |
CY2023Q1 | dei |
City Area Code
CityAreaCode
|
402 | |
CY2023Q1 | dei |
Local Phone Number
LocalPhoneNumber
|
991-5618 | |
CY2023Q1 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2023Q1 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2023Q1 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2023Q1 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2023Q1 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | |
CY2023Q1 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
CY2023Q2 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
4446161 | |
CY2023Q1 | us-gaap |
Cash
Cash
|
7977000 | usd |
CY2022Q4 | us-gaap |
Cash
Cash
|
13277000 | usd |
CY2023Q1 | us-gaap |
Restricted Cash
RestrictedCash
|
950000 | usd |
CY2022Q4 | us-gaap |
Restricted Cash
RestrictedCash
|
0 | usd |
CY2023Q1 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
2045000 | usd |
CY2022Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
705000 | usd |
CY2023Q1 | us-gaap |
Inventory Net
InventoryNet
|
8791000 | usd |
CY2022Q4 | us-gaap |
Inventory Net
InventoryNet
|
9105000 | usd |
CY2023Q1 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
1447000 | usd |
CY2022Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
116000 | usd |
CY2023Q1 | us-gaap |
Assets Current
AssetsCurrent
|
21210000 | usd |
CY2022Q4 | us-gaap |
Assets Current
AssetsCurrent
|
23203000 | usd |
CY2023Q1 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
118000 | usd |
CY2022Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
46000 | usd |
CY2023Q1 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
185000 | usd |
CY2022Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
103000 | usd |
CY2023Q1 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
7769000 | usd |
CY2022Q4 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
150000 | usd |
CY2023Q1 | us-gaap |
Goodwill
Goodwill
|
10787000 | usd |
CY2022Q4 | us-gaap |
Goodwill
Goodwill
|
358000 | usd |
CY2023Q1 | us-gaap |
Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
|
1596000 | usd |
CY2022Q4 | us-gaap |
Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
|
1847000 | usd |
CY2023Q1 | us-gaap |
Assets
Assets
|
41665000 | usd |
CY2022Q4 | us-gaap |
Assets
Assets
|
25707000 | usd |
CY2023Q1 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
4881000 | usd |
CY2022Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
2995000 | usd |
CY2023Q1 | ftlf |
Accrued Expense And Other Liabilities Current
AccruedExpenseAndOtherLiabilitiesCurrent
|
1897000 | usd |
CY2022Q4 | ftlf |
Accrued Expense And Other Liabilities Current
AccruedExpenseAndOtherLiabilitiesCurrent
|
631000 | usd |
CY2023Q1 | us-gaap |
Customer Refund Liability Current
CustomerRefundLiabilityCurrent
|
581000 | usd |
CY2022Q4 | us-gaap |
Customer Refund Liability Current
CustomerRefundLiabilityCurrent
|
590000 | usd |
CY2023Q1 | us-gaap |
Loans Payable Current
LoansPayableCurrent
|
2500000 | usd |
CY2022Q4 | us-gaap |
Loans Payable Current
LoansPayableCurrent
|
0 | usd |
CY2023Q1 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
90000 | usd |
CY2022Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
54000 | usd |
CY2023Q1 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
9949000 | usd |
CY2022Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
4270000 | usd |
CY2023Q1 | us-gaap |
Long Term Loans Payable
LongTermLoansPayable
|
10000000 | usd |
CY2022Q4 | us-gaap |
Long Term Loans Payable
LongTermLoansPayable
|
0 | usd |
CY2023Q1 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
108000 | usd |
CY2022Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
49000 | usd |
CY2023Q1 | us-gaap |
Liabilities
Liabilities
|
20057000 | usd |
CY2022Q4 | us-gaap |
Liabilities
Liabilities
|
4319000 | usd |
CY2023Q1 | us-gaap |
Common Stock Value
CommonStockValue
|
44000 | usd |
CY2022Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
45000 | usd |
CY2023Q1 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
30099000 | usd |
CY2022Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
30056000 | usd |
CY2023Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-8557000 | usd |
CY2022Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-8713000 | usd |
CY2023Q1 | us-gaap |
Translation Adjustment Functional To Reporting Currency Net Of Tax
TranslationAdjustmentFunctionalToReportingCurrencyNetOfTax
|
22000 | usd |
CY2022Q4 | us-gaap |
Translation Adjustment Functional To Reporting Currency Net Of Tax
TranslationAdjustmentFunctionalToReportingCurrencyNetOfTax
|
0 | usd |
CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
21608000 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
21388000 | usd |
CY2023Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
41665000 | usd |
CY2022Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
25707000 | usd |
CY2023Q1 | us-gaap |
Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
|
10738000 | usd |
CY2022Q1 | us-gaap |
Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
|
7294000 | usd |
CY2023Q1 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
6330000 | usd |
CY2022Q1 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
4183000 | usd |
CY2023Q1 | us-gaap |
Gross Profit
GrossProfit
|
4408000 | usd |
CY2022Q1 | us-gaap |
Gross Profit
GrossProfit
|
3111000 | usd |
CY2023Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
2344000 | usd |
CY2022Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
1495000 | usd |
CY2023Q1 | us-gaap |
Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
|
1372000 | usd |
CY2022Q1 | us-gaap |
Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
|
6000 | usd |
CY2023Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
19000 | usd |
CY2022Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
14000 | usd |
CY2023Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
3735000 | usd |
CY2022Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
1515000 | usd |
CY2023Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
673000 | usd |
CY2022Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
1596000 | usd |
CY2023Q1 | us-gaap |
Interest And Other Income
InterestAndOtherIncome
|
84000 | usd |
CY2022Q1 | us-gaap |
Interest And Other Income
InterestAndOtherIncome
|
7000 | usd |
CY2023Q1 | us-gaap |
Interest Expense
InterestExpense
|
98000 | usd |
CY2022Q1 | us-gaap |
Interest Expense
InterestExpense
|
0 | usd |
CY2023Q1 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-82000 | usd |
CY2022Q1 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-0 | usd |
CY2023Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-96000 | usd |
CY2022Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
7000 | usd |
CY2023Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
577000 | usd |
CY2022Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
1603000 | usd |
CY2023Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
421000 | usd |
CY2022Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
313000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
156000 | usd |
CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
1290000 | usd |
CY2023Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.03 | |
CY2022Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.28 | |
CY2023Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.03 | |
CY2022Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.26 | |
CY2023Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
4483000 | |
CY2022Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
4554000 | |
CY2023Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
4935000 | |
CY2022Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
4980000 | |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
21388000 | usd |
CY2023Q1 | ftlf |
Shares Surrendered By Former Employee
SharesSurrenderedByFormerEmployee
|
0 | usd |
CY2023Q1 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
42000 | usd |
CY2023Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
22000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
156000 | usd |
CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
21608000 | usd |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
17346000 | usd |
CY2022Q1 | us-gaap |
Treasury Stock Retired Cost Method Amount
TreasuryStockRetiredCostMethodAmount
|
-0 | usd |
CY2022Q1 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
20000 | usd |
CY2022Q1 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
107000 | usd |
CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
1290000 | usd |
CY2022Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
18772000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
156000 | usd |
CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
1290000 | usd |
CY2023Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
19000 | usd |
CY2022Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
14000 | usd |
CY2023Q1 | ftlf |
Operating Lease Rightofuse Asset Net Of Amortization And Lease Liability
OperatingLeaseRightofuseAssetNetOfAmortizationAndLeaseLiability
|
-16000 | usd |
CY2022Q1 | ftlf |
Operating Lease Rightofuse Asset Net Of Amortization And Lease Liability
OperatingLeaseRightofuseAssetNetOfAmortizationAndLeaseLiability
|
-13000 | usd |
CY2023Q1 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
-14000 | usd |
CY2022Q1 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
-3000 | usd |
CY2023Q1 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
2000 | usd |
CY2022Q1 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
36000 | usd |
CY2023Q1 | us-gaap |
Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
|
42000 | usd |
CY2022Q1 | us-gaap |
Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
|
107000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
917000 | usd |
CY2022Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
741000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-1501000 | usd |
CY2022Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
611000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
|
-251000 | usd |
CY2022Q1 | us-gaap |
Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
|
-309000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
44000 | usd |
CY2022Q1 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
-157000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-1045000 | usd |
CY2022Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
532000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
-16000 | usd |
CY2022Q1 | us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
-13000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
290000 | usd |
CY2022Q1 | us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
22000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
-9000 | usd |
CY2022Q1 | us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
22000 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
232000 | usd |
CY2022Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
1134000 | usd |
CY2023Q1 | us-gaap |
Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
|
17099000 | usd |
CY2022Q1 | us-gaap |
Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
|
-0 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-17099000 | usd |
CY2022Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
0 | usd |
CY2023Q1 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
0 | usd |
CY2022Q1 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
29000 | usd |
CY2023Q1 | us-gaap |
Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
|
12500000 | usd |
CY2022Q1 | us-gaap |
Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
|
0 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
12500000 | usd |
CY2022Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
29000 | usd |
CY2023Q1 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
17000 | usd |
CY2022Q1 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
0 | usd |
CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-4350000 | usd |
CY2022Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
1163000 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
13277000 | usd |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
9897000 | usd |
CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
8927000 | usd |
CY2022Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
11060000 | usd |
CY2023Q1 | us-gaap |
Nature Of Operations
NatureOfOperations
|
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>NOTE <em style="font: inherit;">1</em> - DESCRIPTION OF BUSINESS</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Summary</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">FitLife Brands, Inc. (the “<i>Company</i>”) is a national provider of innovative and proprietary nutritional supplements and wellness products for health-conscious consumers marketed under the following brand names: (i) NDS Nutrition, PMD Sports, SirenLabs, CoreActive, Nutrology, and Metis Nutrition (together, “<i>NDS Products</i>”); (ii) iSatori, BioGenetic Laboratories, and Energize (together, the "<i>iSatori Products</i>"); and (iii) Dr. Tobias, All Natural Advice, and Maritime Naturals (together, the “<i>MRC Products</i>"). The Company distributes the NDS Products principally through franchised General Nutrition Centers, Inc. (“<i>GNC</i>”) stores located both domestically and internationally, and, with the launch of Metis Nutrition, through corporate GNC stores in the United States. The iSatori Products are sold through more than 17,000 retail locations, which include specialty, mass, and online. The Company distributes the MRC Products primarily on Amazon.com.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">FitLife Brands is headquartered in Omaha, Nebraska. For more information on the Company, please go to www.fitlifebrands.com. The Company’s Common Stock, par value $0.01 per share (“<i>Common Stock</i>”), trades under the symbol “FTLF” on the OTC Pink market.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b>Recent Developments</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt;"><i>Acquisition of Mimi</i>’<i>s Rock Corp</i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">On <em style="font: inherit;"> December 4, 2022, </em>the Company entered into an Arrangement Agreement with Mimi’s Rock Corp. (“<i>MRC</i>”), pursuant to which the Company agreed to acquire MRC. On <em style="font: inherit;"> February 28, 2023, </em>the Company completed the acquisition of MRC. See Note <em style="font: inherit;">8</em> for additional disclosure.</p> <p style="margin: 0pt; font-size: 10pt; font-family: "Times New Roman";"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Inflation</i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company has experienced inflationary pressure with regard to the procurement of many of its products. Thus far, the Company has been able to partially offset the impact of inflation through price increases to its customers. In the future, however, further inflationary pressure could adversely affect the Company’s operating performance if market conditions <em style="font: inherit;">no</em> longer permit the Company to pass through price increases to its customers.</p> | |
CY2023Q1 | us-gaap |
Basis Of Accounting
BasisOfAccounting
|
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>NOTE <em style="font: inherit;">2</em> - BASIS OF PRESENTATION</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The accompanying interim condensed unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form <em style="font: inherit;">10</em>-Q and Article <em style="font: inherit;">8</em> of Regulation S-<em style="font: inherit;">X.</em> Accordingly, they do <em style="font: inherit;">not</em> include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In our opinion, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation are included. Operating results for the <em style="font: inherit;">three</em>-month period ended <em style="font: inherit;"> March 31, 2023 </em>are <em style="font: inherit;">not</em> necessarily indicative of the results that <em style="font: inherit;"> may </em>be expected for the year ending <em style="font: inherit;"> December 31, 2023. </em>Although management of the Company believes the disclosures presented herein are adequate and <em style="font: inherit;">not</em> misleading, these interim consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the footnotes thereto included in our Annual Report on Form <em style="font: inherit;">10</em>-K for the fiscal year ended <em style="font: inherit;"> December 31, 2022, </em>filed with the Securities and Exchange Commission (the “<i>SEC</i>”) on <em style="font: inherit;"> March 24, 2023.</em></p> | |
CY2022Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.26 | |
CY2023Q1 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Use of Estimates and Assumptions</i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect (i) the reported amounts of assets and liabilities, (ii) the disclosure of contingent assets and liabilities known to exist as of the date the financial statements are published, and (iii) the reported amount of net sales and expense recognized during the periods presented.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Those estimates and assumptions include estimates for reserves of uncollectible accounts receivable, allowance for inventory obsolescence, depreciable lives of property and equipment, purchase price allocations for business combinations, analysis of impairment of goodwill, realization of deferred tax assets, accruals for potential liabilities and assumptions made in valuing stock instruments issued for services. Management evaluates these estimates and assumptions on a regular basis. Actual results could differ from those estimates.</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"> </p> | |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
156000 | usd |
CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
1290000 | usd |
CY2023Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
4483000 | |
CY2022Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
4554000 | |
CY2023Q1 | us-gaap |
Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
|
452000 | |
CY2022Q1 | us-gaap |
Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
|
426000 | |
CY2023Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
4935000 | |
CY2022Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
4980000 | |
CY2023Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.03 | |
CY2022Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.28 | |
CY2023Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.03 | |
CY2023Q1 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Customer Concentration</i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 36pt;">Net sales to GNC during the <em style="font: inherit;">three</em>-month periods ended <em style="font: inherit;"> March 31, 2023 </em>and <em style="font: inherit;">2022</em> represent 49% and 70% of total net revenue, respectively. Gross accounts receivable attributable to GNC as of <em style="font: inherit;"> March 31, 2023 </em>and <em style="font: inherit;">2022</em> represent 32% and 82% of the Company’s total accounts receivable balance, respectively.</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:34pt;"> </p> | |
CY2023Q1 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.730 | pure |
CY2022Q1 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.195 | pure |
CY2023Q1 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
110000 | usd |
CY2022Q4 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
107000 | usd |
CY2023Q1 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
7972000 | usd |
CY2022Q4 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
8347000 | usd |
CY2023Q1 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
929000 | usd |
CY2022Q4 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
865000 | usd |
CY2023Q1 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
110000 | usd |
CY2022Q4 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
107000 | usd |
CY2023Q1 | us-gaap |
Inventory Net
InventoryNet
|
8791000 | usd |
CY2022Q4 | us-gaap |
Inventory Net
InventoryNet
|
9105000 | usd |
CY2023Q1 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
897000 | usd |
CY2022Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
902000 | usd |
CY2023Q1 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
779000 | usd |
CY2022Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
856000 | usd |
CY2023Q1 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
118000 | usd |
CY2022Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
46000 | usd |
CY2023Q1 | us-gaap |
Depreciation
Depreciation
|
19000 | usd |
CY2022Q1 | us-gaap |
Depreciation
Depreciation
|
14000 | usd |
CY2023Q1 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
2500000 | usd |
CY2022Q4 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
0 | usd |
CY2023Q1 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
10000000 | usd |
CY2022Q4 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
0 | usd |
CY2023Q1 | us-gaap |
Long Term Debt
LongTermDebt
|
12500000 | usd |
CY2022Q4 | us-gaap |
Long Term Debt
LongTermDebt
|
0 | usd |
CY2023Q1 | us-gaap |
Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
|
1875000 | usd |
CY2023Q1 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
|
2500000 | usd |
CY2023Q1 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
|
2500000 | usd |
CY2023Q1 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
|
2500000 | usd |
CY2023Q1 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
|
2500000 | usd |
CY2023Q1 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
|
625000 | usd |
CY2023Q1 | us-gaap |
Long Term Debt
LongTermDebt
|
12500000 | usd |
CY2023Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
60000000.0 | |
CY2023Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
CY2023Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
4446000 | |
CY2022Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
4507000 | |
CY2023Q1 | us-gaap |
Treasury Stock Common Shares
TreasuryStockCommonShares
|
0 | |
CY2023Q1 | ftlf |
Shares Forfeited During Period Shares
SharesForfeitedDuringPeriodShares
|
61200000 | |
CY2023Q1 | ftlf |
Shares Forfeited During Period Value
SharesForfeitedDuringPeriodValue
|
0 | usd |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
379000 | |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
3.09 | |
CY2022 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P5Y3M18D | |
CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
0 | |
CY2023Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
0 | |
CY2023Q1 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
-0 | |
CY2023Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
0 | |
CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
-0 | |
CY2023Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
0 | |
CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
379000 | |
CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
3.09 | |
CY2023Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P5Y1M6D | |
CY2023Q1 | us-gaap |
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
|
379000 | |
CY2023Q1 | us-gaap |
Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
|
P5Y1M6D | |
CY2023Q1 | us-gaap |
Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
|
3.09 | |
CY2023Q1 | us-gaap |
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
|
340000 | |
CY2023Q1 | us-gaap |
Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
|
2.63 | |
CY2023Q1 | us-gaap |
Share Price
SharePrice
|
16.75 | |
CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
5231000 | usd |
CY2023Q1 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
|
143000 | usd |
CY2023Q1 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
143000 | |
CY2023Q1 | us-gaap |
Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
|
2238000 | usd |
CY2023Q1 | ftlf |
Class Of Warrant Or Right Issued During Period
ClassOfWarrantOrRightIssuedDuringPeriod
|
0 | |
CY2023Q1 | ftlf |
Class Of Warrant Or Right Expired During Period
ClassOfWarrantOrRightExpiredDuringPeriod
|
0 | |
CY2023Q1 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
1.15 | |
CY2023Q1 | us-gaap |
Reclassifications
Reclassifications
|
<p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b>NOTE <em style="font: inherit;">10</em> – RECLASSIFICATIONS</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">Certain prior year amounts have been reclassified to conform to current presentation. These reclassifications had <em style="font: inherit;">no</em> effect on the reported operating income or net income on the Condensed Consolidated Statement of Operations. Certain expenses previously classified as selling, general and administrative expenses have been reclassified to a contra-revenue account on the Condensed Consolidated Statement of Operations.</p> |